baber/WOPTO huggingface dataset:
Patent NZ-562516-A (NZ)
Title: Push-button switch
Inventor: CALDERARA ENNIO
IPC: H01H13/14
Filed: 2006-04-03
Abstract: Disclosed is a push-button switch which comprises: a box-like supporting structure (2) defining an inner chamber (8), the box-like structure (2) having at least one opening (9) communicating with the inner room (8) and having an opening axis (Z-Z); a push-button (21) to be matched with the supporting structure (2) at the opening (9); mechanical coupling means (22) for coupling the push- button (21) to the structure (2) such that the push- button (21) is allowed to be fastened to the supporting structure (2) while being movable relative thereto in a direction substantially parallel to the opening axis (Z- Z). The push-button switch is characterized in that the mechanical coupling means include a holding and guide frame (22) for the push-button (21), which can be fixed to the supporting structure (2) and can be interposed between the push-button (21) and the structure (2).
Patent NZ-565935-A (NZ)
Title: Actuator controller with logic to identify actuator types and change parameters based on the tpye
Inventor: MATTES JOHN
IPC: A61G5/00
Filed: 2006-08-31
Abstract: Disclosed is an actuator controller for operating one of a plurality of seat and leg support position actuators of a wheelchair. The actuator controller comprises a controller and an actuator circuit, the circuit coupled to the controller for driving any one of the plurality of seat and leg support position actuators. The controller comprises logic for: reading identification data associated with a plurality of actuator types; identifying an actuator type based on the data; selecting operational parameters for the actuator based on the identification; and controlling the circuit to drive the actuator in accordance with the selected parameters.
Patent NZ-567968-A (NZ)
Title: Mechanical ventilation in the presence of sleep disordered breathing
Inventor: DOUGLAS ROBERT
IPC: A61M16/00
Filed: 2004-12-24
Abstract: Disclosed is a method for determining the presence of mouth leak. The method is for apparatus having a blower adapted to provide a supply of breathable gas to a patient at positive pressure and a mechanism for monitoring the flow of gas in the apparatus. The method comprises the steps of: determining a measure of leak volume during inspiratory portions of respiratory cycles of the patient; determining a measure of leak volume during expiratory portions of respiratory cycles of the patient; and determining the presence of mouth leak depending on the relative values of the two respective determined measures of leak volume.
Patent NZ-571254-A (NZ)
Title: A mid-IR optical nose system comprising a tunable seed laser, a pulsed pump laser and an optical parametric generator - optical parametric amplifier (OPG-OPA) and method for using the same.
Inventor: MIROV SERGEY
IPC: G01N21/39
Filed: 2007-02-13
Abstract: An optical nose (optical molecular detection) system (10) with a broadly tunable, narrow linewidth mid-IR laser source with a modular structure. The laser source comprises the following: a) A tunable seed laser unit (24) including a single-longitudinal mode and a widely tunable TM2+:II-VI master oscillator (12) with a TM2+:II-VI power amplifier (14). The symbol TM2+ represents a transition metal ion selected from the group consisting of Cr2+, Fe2+, Co2+ and Ni2+ and II-VI represents ZnS, ZnSe, CdS, CdSe, ZnTe or CdTe and their mixtures. b) A pulsed pump laser unit including a single-frequency, high energy, Q-switch laser (16). c) An Optical Parametric Generator-Optical Parametric Amplifier (OPG-OPA) (20), pumped by the pulsed pump laser unit (16) and seeded by the seed tunable laser unit (24) having a mid-IR output that is selectively variable over about 2 to 20ìm. A method of analysing a gaseous sample using such a system is also disclosed.
Patent NZ-573184-A (NZ)
Title: Playing field with signs having a contrast strength resulting in them not being distinguishable from a distance
Inventor: ULRICH FRANZ
IPC: E01C23/16
Filed: 2007-05-22
Abstract: Disclosed is a playing field (1) for a sporting occasion. The field has marked lines (2) related to a sport that is played on the playing field; and approximately uniformly distributed signs (5, 5'), either in rows or according to a specified pattern, arranged on at least approximately a total playing field. Contrast strength and dimensions of the signs are selected such that individual ones of the signs are only recognizable by close-up images taken by a camera dependent upon resolution of a picture transfer system and the visual acuity of a viewer. Contrast strength of the marked lines is greater than contrast strength of the signs.
Patent NZ-577119-A (NZ)
Title: Treatment of microbial infections such as mastitis with a peroxide generating system
Inventor: BRAGGER JUDITH MARY
IPC: A61K31/7004
Filed: 2010-05-20
Abstract: Disclosed is a method of treating or preventing mastitis in a non-human animal, said method comprises the step of applying a medicament to the mammary gland of the non-human animal; wherein the medicament contains an extended acting oxygen generating system which has at least two components: (i) one component being a slow release hydrogen peroxide generation system, and; (ii) another component being an activator in the form of a halide or thiocyanate substrate; wherein the extended acting oxygen generating system is configured to provide oxygen generation over a time period between 30 seconds to 14 hours following administration to an animal, and the two or more components present in the medicament are in a form prior to administration to an animal that prevents oxygen generation until during or after administration and controlled thereafter.
Patent NZ-578541-A (NZ)
Title: Dna vaccines for fish
Inventor: KRIMAN FLEIDERMAN SALOMON LUIS
IPC: C12N15/40
Filed: 2007-12-20
Abstract: Provided is a fish vaccine based on Infectious Pancreatic Necrosis virus (IPNv) VP2 protein. The vaccine is formulated with liposome DOTAP. Further provided are methods of producing the vaccine, and foods containing the vaccine.
Patent NZ-579914-A (NZ)
Title: Light-directing led apparatus with compound outer lens surface
Inventor: WILCOX KURT S
IPC: G02B3/02
Filed: 2008-03-25
Abstract: LED apparatus for illumination toward a preferential side, including a light emitter (18) having at least one LED on a base, a primary lens (16) positioned over the light emitter and having a central axis (26), and a secondary lens (20) placed with an inner surface surrounding the primary lens. The secondary lens has a base-adjacent lower end defining a main plane substantially perpendicular to the central axis, and a compound outer lens surface (24) with a middle-region reference point defining a reference axis parallel to the central axis. The compound outer lens surface includes (A) a principal perimeter surface centred on the preferential side, the principal perimeter surface (a) projecting to a ridgeline subtending an angle of at least about 90 degrees about the central axis, and (b) terminating inwardly at the ridgeline, (B) a middle region containing the reference point and having a concavity thereabout, and (C) a non-principal perimeter surface centred on the non- preferential side and adjoining the middle region and the principal perimeter surface.
Patent NZ-583871-A (NZ)
Title: Method for increasing the resistance of plants to abiotic stress comprising spraying said plants with a composition comprising a xyloglucan derivative
Inventor: SALVADOR PASCAL
IPC: A01P21/00
Filed: 2007-08-27
Abstract: 583871 Disclosed is a process for adapting plants to an abiotic stress or to a hydric stress wherein said process comprises at least a step of treatment of the plants by foliar field spraying with a composition comprising at least one xyloglucan polymer or oligomer at a concentration of 0.01 g to 2 g /ha of said xyloglucan polymer or oligomer, said spraying step being realised between 1 and 72 hours before the stress arrives
Patent NZ-584551-A (NZ)
Title: Receiving elevator commands by detecting movements of a user or user device
Inventor: GERSTENKORN BERNHARD
IPC: B66B1/46
Filed: 2008-10-27
Abstract: Disclosed is a lift installation (10) with at least one lift (12, 14, 16), a control unit and at least one destination call device (20). The destination call device (20) is comprised of a selecting unit, a radio device and a screen. The destination call device (20) makes known several destination calls to the user and, by means of the selecting unit, allows the selection of a destination call in accordance with at least one destination call selection signal. The radio device activates a data communication between the radio device and a communications unit (40), which is carried by the user, within a specific range of a radio link section of the radio device. The radio device detects a movement of the communications unit (40) as a radio signal of greater or lesser strength and the destination call device converts the radio signal into a destination call selection signal. The screen of the destination call device (20) shows several fields associated with the destination calls and an indicator. The indicator can be imaged on the screen by means of the selecting unit in accordance with the destination call selection signal and is movable to one of the fields in order to select a destination call.
Patent NZ-590289-A (NZ)
Title: Anticancer compounds, in particular stellatolide a and b, isolated from ecionemia acervus bowerbank 1864
Inventor: RODRIGUEZ ACEBES RAQUEL
IPC: A61K38/08
Filed: 2009-07-16
Abstract: Disclosed herein is a cyclic depsipeptide compound of formula (I), wherein the substituents are as defined within the specification, in particular Stellatolide A and B, processes for their isolation for a sponge of the family Ancorinidae, genus Ecionemia, species Ecionemia acervus Bowerbank 1864, and pharmaceutical compositions comprising said compounds. Such compounds are useful as anticancer agents.
Patent NZ-603806-A (NZ)
Title: Bleach particles with a sodium percarbonate core coated with a bleach activator
Inventor: LEININGER STEFAN
IPC: C11D3/02
Filed: 2011-04-27
Abstract: ABSTRACT - 603806 The disclosure relates to a Bleach particle comprising: (a) a core consisting essentially of sodium percarbonate, (b) an inner coating layer comprising at least 50% by weight of sodium sulfate in the form of thenardite or burkeite, and (c) an outer coating layer comprising a water-soluble binder (preferably selected from sodium silicates, polymers of acrylic acid and methacrylic acid and copolymers of acrylic acid with methacrylic acid, acrolein or vinyl monomers containing sulfonic acid groups) and at least one bleach activator selected from perhydrolyzable N-acyl compounds and a-acyl compounds.
Patent NZ-605796-A (NZ)
Title: Method and apparatus for the purification of carbon dioxide using liquid carbon dioxide
Inventor: FIND RASMUS
IPC: C01B32/50
Filed: 2010-06-17
Abstract: A method for removing contaminants from a gaseous or liquid stream (f) substantially comprising carbon dioxide comprises a purification step in a column having a top, bottom and an intermediate section. The purification step provides a contaminant lean stream (g2) leaving the top section of the column and a contaminant rich liquid stream (l2) leaving, optionally the bottom section of, the column. The containment rich liquid stream is fed to a reboiler (A3). The contaminant lean stream leaving the top section of the column is further subjected to a series of steps selected from two options. The first option (see figure 1) includes compressing the contaminant lean stream providing a compressed gaseous stream (g4), cooling the compressed gaseous stream in the reboiler providing at least a product stream (p) and a gaseous stream (g3), and feeding the gaseous stream to the column at the bottom section of the column. The second option (see figure 2) includes cooling the contaminant lean stream in the reboiler providing at least a product stream and a gaseous stream, compressing the gaseous stream providing a cooled compressed gaseous stream (g4’), and feeding the cooled compressed gaseous stream to the column at the bottom section of the column and depressurising the contaminant rich liquid stream leaving the bottom section of the column before entering the reboiler. The purification step may be selected from absorption using an absorbent when the feed stream is gaseous, and rectification having a liquid phase, when the feed stream is liquid, wherein the absorbent and liquid phase is liquid carbon dioxide.
Patent NZ-611564-A (NZ)
Title: Gas delivery device and system
Inventor: BATHE DUNCAN P
IPC: G05D7/06
Filed: 2011-01-06
Abstract: A gas delivery system including a gas delivery device (100), a control module (200) and a gas delivery mechanism is disclosed. It is important when administering gas therapy to patients to verify the correct type of gas and the correct concentration are being used. It is also important to verify dosage information and administration. This system helps verify these parameters by storing information about the gas cylinder and transmitting this information to the gas delivery device. The gas delivery device integrates with a computerized system to ensure that patient information contained within the computerized system matches the gas that is to be delivered by the gas delivery device. An exemplary gas delivery device includes a valve (107) assembly with a valve and circuit including a memory, a processor and a transceiver in communication with the memory. The memory may include gas data such as gas identification, gas expiration and gas concentration. The transceiver on the circuit of the valve assembly may send wireless optical line - of - sight signals (300) to communicate the gas data to the control module. Exemplary gas delivery mechanisms include a ventilator (400) and a breathing circuit (410). Methods of administering gas are also described.
Patent NZ-618684-A (NZ)
Title: Oxazepines as ion channel modulators
Inventor: PERRY THAO
IPC: C07D498/04
Filed: 2012-06-29
Abstract: The disclosure relates to compounds of formula I that are sodium channel inhibitors, wherein Y, Z R1, R3 and n are as described in the specification. The disclosure also relates to their use the treatment of various disease states, including cardiovascular diseases and diabetes. The cardiovascular disease may be atrial and ventricular arrhythmias, heart failure (including congestive heart failure, diastolic heart failure, systolic heart failure, acute heart failure), Prinzmetal’s (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, ischemia, recurrent ischemia, reperfusion injury, myocardial infarction, acute coronary syndrome, peripheral arterial disease, pulmonary hypertension or intermittent claudication. Example compounds include: (R)-tert-butyl3-(7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][1 ,4]oxazepin-5-ylamino)pyrrolidine-1-carboxylate, N-(cyclopropylmethyl)-7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][1,4]oxazepin-5-amine, 5-(pyrrolidin-1-yl)-7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][1,4]oxazepine N -cyclopropyl-7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][1,4]oxazepin-5-amine N-benzyl-N-methyl-7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][1,4]oxazepin-5-amine N-((3-fluoropyridin-2-yl)methyl)-7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][1,4]oxazepin-5-amine N-(pyridin-2-ylmethyl)-7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][1,4]oxazepin-5-amine N-(cyclopropylmethyl)-7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][1,4]oxazepin-5-amine (S)-tert-butyl 1-(7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][1,4]oxazepin-5-yl)pyrrolidin-3-ylcarbamate N-(2-(IH-imidazol-I-yl)ethyl)-7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][1,4]oxazepin-5-amine (S)-N,N-dimethyl-1-(7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][1,4]oxazepin-5-yl)pyrrolidin-3-amine N-(pyridin-2-yl)-7-(4-(trifluoromethyl)phenyl)-2,3-dihydrobenzo[f][I,4]oxazepin-5-amine
Patent NZ-624771-A (NZ)
Title: Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
Inventor: DIBAS MOHAMMED I
IPC: A61P17/00
Filed: 2012-11-08
Abstract: Provided is the use of 7-(1H-Imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline or its enantiomers in the treatment of skin diseases and conditions in a patient in need thereof.
Patent NZ-626468-A (NZ)
Title: Smoking article comprising an isolated combustible heat source
Inventor: MIRONOV OLEG
IPC: A24D1/22
Filed: 2013-02-12
Abstract: A smoking article (2) comprises: a combustible heat source (4)with opposed front and rear faces; an aerosol-forming substrate (6) downstream of the rear face of the combustible heat source (4); an outer wrapper (12) circumscribing the aerosol- forming substrate and at least a rear portion of the combustible heat source;and one or more airflow pathways along which air may be drawn through the smoking article (2) for inhalation by a user. The combustible heat source (4) is isolated from the one or more airflow pathways such that air drawn through the smoking article (2) along the one or more airflow pathways does not directly contact the combustible heat source (4).
Patent NZ-703552-A (NZ)
Title: Method for removing an ester from a vapor mixture
Inventor: LOVIAT FRANÇOIS
IPC: B01D53/96
Filed: 2013-04-23
Abstract: A method for the removal of an ester from a vapor mixture containing the ester is disclosed. The method comprises the steps of: a step (210) of bringing the vapor mixture into contact with an aqueous solution containing the acid corresponding to the ester, a step (220) where a portion of the ester is dissolved in or otherwise transferred to the aqueous solution, and a step (230) where the aqueous solution is after the contact led in a circulation, the aqueous solution is processed in the circulation in a process comprising: a heating step (240), a reaction step (250) having a residence time and a temperature, a cooling step (260), wherein the heating step (240) precedes the reaction step (250), the reaction step (250) precedes the cooling step (260), and the residence time and the temperature in the reaction step (250) are sufficient to substantially reduce the content of the ester in the aqueous solution. The invention further relates to an apparatus for carrying out said process. The present invention further relates also to the use of the apparatus in the method of the invention, preferably in the production of a lactide or a polylactic acid polymer.
Patent NZ-719282-A (NZ)
Title: Anti-staining coating composition
Inventor: MARAL JEAN-LUC
IPC: C09D5/00
Filed: 2014-10-23
Abstract: The invention provides a coating composition for a food or beverage container. The coating composition comprises an additive being operable to disrupt the chromophore of a colourant upon absorption of the colourant into the cured coating composition, for example any substance that interacts with the chromophore of the colourant to thereby change the colour of the chromophore. The coating composition further comprises a crosslinking agent. The coating compositions advantageously reduce or prevent staining through the interaction of the additive with the interaction with the chromophore of the colourant.
Patent NZ-734043-A (NZ)
Title: Compositions containing arsenic and their use in methods of treatment
Inventor: EUTICK MALVIN
IPC: A61K33/36
Filed: 2016-01-29
Abstract: A pharmaceutical composition is provided comprising a highly soluble arsenic carbonate and/or bicarbonate compound and which is useful in the treatment of a variety of cancers, including acute promyelocytic leukaemia. The arsenic carbonate and/or bicarbonate salt acts as a solid, and so orally deliverable, improved bioequivalent delivery form of arsenic trioxide IV solutions.
Patent NZ-735051-A (NZ)
Title: Methods and compositions for rapid multiplex amplification of str loci
Inventor: SCHUMM JAMES
IPC: C12N15/10
Filed: 2012-05-11
Abstract: A method of multiplex amplification of DNA molecules comprising a plurality of loci, the method comprising: a) providing at least 23 loci; b) amplifying the loci in a single amplification reaction wherein 5 of the STR loci are D3S1358, D8S1179, D18S51, D21S11, and FGA and at least 18 STR loci of said plurality are selected from the group consisting of D19S433, D2S1338, D16S539, Penta D, D5S818, D13S317, D7S820, TPOX, CSF1PO, Penta E, SE33, D1S1656, D10S1248, D2S441, Penta C, D12S391, D22S1045, DYS391, D6S1043, TH01, and vWA, and wherein 6 or more different labels are utilized to label one member of each primer pair for each of said loci.
Patent NZ-766984-A (NZ)
Title: Antibody-drug conjugate having acidic self-stabilization junction
Inventor: ZHU YI
IPC: A61K47/68
Filed: 2018-06-15
Abstract: The present invention provides a special drug conjugate having a hydrophilic acidic stabilization junction. Compared with a conjugate having a lower drug loading, due to the introduction of the acidic stabilization junction, the conjugate in the present invention can also have a higher drug loading (that is, each targeted reagent has more hydrophilic drug junctions), keeps a desired PK property and has a same or better activity in a body.
Patent PT-101797-A (PT)
Inventor: BLANEY TED LEE
IPC: A61F13/58
Filed: 1995-11-20
Abstract: Disposable absorbent articles such as baby diapers or adult incontinent briefs provided with a refastenable adhesive fastening system. The adhesive fastening system preferably comprises a pair of tape tabs each having an adhesive surface which during use is adhered to a landing member having an adherence surface which may comprise only the backsheet that has no reinforcement for strength against tearing or may comprise a reinforced backsheet. The invention improves bond security while at the same time making the fastening system more easy to remove without tearing by careful optimization of the properties of the adhesive, the tape tab, and the landing member. In particular, it has been found that the adhesive fastening system should have a Standard Shear Hang Time of greater than about 1000 minutes per square inch. The surface characteristics, toughness, and elasticity modulus of the landing member is optimized while the adhesive aggressiveness (quick-stick) of the adhesive is optimized with preferred low coating weights of the adhesive and low calculated caliper for the landing member so as to provide an adhesive fastening system that bonds easily, holds securely and is refastenable.